U.S. Entertainment Stock News

In recent days, attention on Waste Management has intensified ahead of its April 28, 2026 earnings release, as analysts highlight expectations for higher quarterly and full‑year profit and revenue alongside the company’s ongoing share repurchase program and decades-long pattern of dividend increases. This combination of anticipated profit growth, sustained capital returns, and growing interest in recycling and renewable natural gas has become a key focus for investors reassessing Waste...

Vertiv Holdings Co recently committed about US$50 million to expand its Ironton manufacturing plant and Westerville headquarters in Ohio, aiming to boost liquid cooling and chilled water system capacity for AI and high-density computing while adding hundreds of jobs through 2029. This expansion underpins Vertiv’s broader role as a critical provider of power and thermal infrastructure for AI data centers, reinforcing its ability to meet rising demand with shorter supply chains and greater...

In early April 2026, Anthropic, Genentech, IBM, Meta, Microsoft, and others launched the Shared AI License Foundation and IBM expanded its AI, quantum, and hardware collaborations, while also securing FedRAMP authorization for 11 watsonx and automation tools and settling a US$17,000,000 U.S. DEI probe. Together, these moves underline IBM’s push to position itself at the center of open, enterprise-grade AI and quantum infrastructure while addressing regulatory scrutiny. We’ll now explore how...

Array Technologies, Inc. recently disclosed that seven independent directors, including long-serving members and newer renewable-energy specialists, will not stand for re-election at the May 19, 2026 annual meeting, while also proposing to phase out its classified board structure in favor of annual director elections by 2029. This combination of significant board turnover and a move toward annual elections signals a shift in corporate governance that may recalibrate how investors assess...

On 9 April 2026, Amneal Pharmaceuticals announced it had launched bimatoprost ophthalmic solution 0.01% in multiple vial sizes, a generic equivalent to Allergan’s LUMIGAN indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This launch adds a high-usage ophthalmic therapy with approximately US$719 million in recent U.S. annual sales to Amneal’s generics portfolio, underlining its focus on expanding access to lower-cost treatments...

In early April 2026, Mohawk Industries filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to replace supermajority voting thresholds with a simple majority standard in its charter and bylaws. This clash over corporate governance comes as Mohawk is already in the spotlight for mixed quarterly results, efficiency initiatives, and active capital returns. We’ll now examine how this governance dispute, alongside Mohawk’s recent restructuring...

The Federal Energy Regulatory Commission’s decision to lower allowed returns for New England transmission owners is set to trim Eversource Energy (ES) 2026 after-tax earnings, prompting updated guidance and raising fresh questions for income-focused investors. See our latest analysis for Eversource Energy. At a share price of US$69.97, Eversource’s recent 5.4% 1 month share price decline contrasts with a 3.2% 3 month share price gain and a 30.0% 1 year total shareholder return. This suggests...

Cohen & Steers recently reported preliminary assets under management of US$93.10 billion as of March 31 2026, down from US$98.40 billion a month earlier, with the decline mainly linked to market depreciation and client distributions, partly offset by net inflows. This shift in assets under management highlights how market conditions and payout decisions can affect fee-earning assets even when new client money is coming in. We’ll now explore how this recent assets-under-management decline may...

In recent weeks, Brigade Group subsidiaries BCV Developers and Brigade Hotel Ventures announced new management agreements with Hyatt for Hyatt House Bengaluru Devanahalli, slated to open in 2027, and Grand Hyatt Chennai ECR, targeted for 2029, while Hyatt Regency Niagara Falls Fallsview joined the World of Hyatt portfolio and Caption by Hyatt Chattanooga Downtown opened as the brand’s first property in the city. Taken together, these openings and signings highlight Hyatt’s push into...

Roivant Sciences recently reported that Priovant has begun enrolling patients in a seamless Phase 2b/3 trial of brepocitinib for lichen planopilaris and released past topline Phase 3 data from Immunovant’s batoclimab thyroid eye disease studies, which did not meet their primary endpoint but showed consistent safety. The update underscores Roivant’s growing late-stage immunology pipeline, led by brepocitinib’s FDA Priority Review in dermatomyositis and multiple additional indications...

In late March and early April 2026, UroGen Pharma announced publication of pivotal Phase 3 ENVISION data for bladder cancer therapy ZUSDURI and launched its “LG-UTUC Luminaries” program to recognize leaders in kidney-sparing care for rare upper tract urothelial cancer. Together, these steps highlight UroGen’s push to embed ZUSDURI’s evidence into clinical practice while deepening relationships with urologists focused on organ-preserving cancer management. Next, we’ll examine how the ENVISION...

Why Babcock & Wilcox Enterprises (BW) is in Focus Today Pomerantz LLP has opened an investigation into Babcock & Wilcox Enterprises (BW) for possible securities law violations, following a Wolfpack Research report on alleged conflicts tied to a $2.4b power generation contract. The short seller claims and legal scrutiny have drawn fresh attention to BW, prompting investors to reassess the company’s governance, risk profile, and how the stock’s recent moves compare with its underlying...

Sector momentum and guidance upgrade put Axalta in focus Axalta Coating Systems (AXTA) caught investor attention after a sharp move that aligned with a broader specialty chemicals rally, while its recent upgrade to first quarter and full year 2024 guidance added another clear catalyst. The company cited stronger Refinish and Industrial performance behind the guidance change. This, combined with supportive analyst sentiment, has pushed investors to reassess the risk and reward profile of the...

Why M&T Bank Is Drawing Investor Attention Now M&T Bank (MTB) has been drawing attention after recent share price moves, with the stock up around 8% over the past month and about 4% over the past 3 months. For investors tracking regional banks, this recent performance is prompting a closer look at how M&T Bank’s earnings profile, balance sheet and valuation compare with broader U.S. financials and other large regional peers. See our latest analysis for M&T Bank. Beyond the recent gains, M&T...

In April 2026, Flowco Holdings Inc. filed a shelf registration to offer 1,454,849 shares of Class A common stock, totaling about US$29.97 million, in connection with an ESOP-related transaction. This ESOP-focused shelf registration highlights a potential shift in Flowco’s capital structure and underscores the company’s emphasis on broadening employee ownership. We’ll now examine how this ESOP-related shelf registration might reshape Flowco’s investment narrative, particularly around capital...

Tennant (TNC) has put autonomous cleaning in focus with the launch of its X16 SWEEP robotic sweeper for warehouses, logistics centers and light manufacturing, an event that spotlights the company’s automation ambitions. See our latest analysis for Tennant. The share price has moved to $77.50, with a 7 day share price return of 10.97% and a 30 day share price return of 21.40%. The 1 year total shareholder return of 10.81% and 3 year total shareholder return of 21.09% suggest momentum has...

In early April 2026, Southern Methodist University announced a partnership with AECOM to advance artificial-intelligence-driven research, workforce readiness, and doctoral-level talent development in infrastructure engineering through a new fellowship program at SMU’s Lyle School of Engineering. This collaboration links AECOM’s complex infrastructure expertise with SMU’s research capabilities, aiming to turn AI-focused academic work into practical engineering solutions while preserving...

Coca-Cola FEMSA, S.A.B. de C.V. previously announced a quarterly dividend of US$0.9636 per share, payable on May 1, 2026, to shareholders of record on April 20, 2026, with the same date as the ex-dividend date. This higher cash payout highlights the company’s emphasis on returning capital to shareholders and may be interpreted as a sign of financial resilience. Next, we’ll examine how this increased quarterly dividend affects Coca-Cola FEMSA’s investment narrative, especially its focus on...

Zentalis Pharmaceuticals recently reported that a 400mg once-daily, 5-days-on/2-days-off regimen of azenosertib was selected as the optimal monotherapy dose for Cyclin E1-positive platinum-resistant ovarian cancer, following a prespecified interim analysis from the DENALI Part 2a Phase 2 trial. This dose decision, supported by a differentiated response rate, comparable safety and plans for inclusion in both the pivotal DENALI Phase 2 and confirmatory ASPENOVA Phase 3 trials, is central to...

Earlier this week, Frontline PLC was flagged as trading very far above its estimated intrinsic GF Value, while its financial strength was rated a relatively low 4/10 despite an overall GF Score of 74. This mix of perceived overvaluation and balance sheet concerns has sharpened investor focus on whether Frontline’s fundamentals fully underpin its current market optimism. Next, we’ll examine how concerns about Frontline’s low financial strength score may reshape its existing investment...

Allegro MicroSystems (ALGM) has been under pressure as continued end market softness has coincided with declining sales over the past two years, weaker earnings per share, and a low free cash flow margin. See our latest analysis for Allegro MicroSystems. The recent share price momentum tells a different story to the earnings pressure, with a 7 day share price return of 15.03% and year to date share price return of 39.35%. The 1 year total shareholder return of 68.69% contrasts with a 3 year...

Mphasis has completed a large-scale technology modernization program for Flagstar Bank National Association (FLG), consolidating six legacy data centers into two modern facilities and migrating hundreds of critical applications with a focus on resilience and scalability. See our latest analysis for Flagstar Bank National Association. The completion of this infrastructure overhaul comes after a period where the share price return has picked up in the short term, with a 30 day share price...

Freshpet recently reported crossing US$1.00 billion in annual net sales, nearly doubling operating income and generating positive free cash flow ahead of its original timeline. These results, combined with expanding e-commerce and fridge placements in retailers like Costco, have led several analysts to upgrade their views on the company’s prospects despite rising competition. Now we’ll explore how Freshpet’s earlier-than-planned shift to positive free cash flow may influence its broader...

Research analysts at Keefe, Bruyette & Woods recently upgraded United Community Banks to an “outperform” rating, reflecting a stronger institutional view of the regional lender’s prospects following its record of dividend increases and supportive earnings expectations. This shift in analyst sentiment comes as United Community Banks offers a dividend yield above both its regional banking peers and the broader US market, highlighting income as a central part of the investment case. We’ll now...